Camtek
Camtek's revenue rose 15.6% to $496 million in fiscal 2025. Its operating margin was 25.8%, up from 25.2% a year earlier. Free cash flow was $127 million, up 13.7%. The diluted share count rose 1.2%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
What Camtek does
Camtek, an Israeli company, makes inspection and metrology equipment for the semiconductor industry. Its machines scan silicon wafers during production, using optics and software to find defective chips and measure their features. Its customers are chipmakers, foundries and firms that assemble and test chips.
Its systems are used in advanced packaging, chiplets, high-bandwidth memory, compound semiconductors, memory chips, image sensors, power chips and similar fields. It sells systems and support worldwide, with direct customer support through subsidiaries in 8 offices. In November 2023 it bought FRT, a German supplier of precision measurement tools for advanced packaging and silicon carbide.
Its sales are concentrated in Asia. In 2025, sales in the Asia Pacific region, mostly China, Taiwan and South Korea, were about 91% of its total revenues.
Its biggest risks, as it describes them
- Most of its sales come from Asia, so a downturn there or in China would hit it hard.
- A few customers account for a large share of revenue.
- Hostilities in Israel and nearby could disrupt its operations, shipments and supplies.
- Two shareholders, Priortech and Chroma, vote together and share joint control over the company.
Income statement
From fiscal 2016 to 2025, earnings per share grew 26.0% a year and net income 30.2% a year, as new shares raised the share count by 41% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 242 | 148 | 139 | 157 | 257 |
| Debt incl. finance leases | 195 | 196 | 197 | 203 | 525 |
| Net debt (negative means net cash) | −47 | 48 | 58 | 46 | 269 |
| Net debt to EBITDA | −0.6x | 0.6x | 0.8x | 0.4x | 1.9x |
| Debt to equity | 0.7x | 0.5x | 0.4x | 0.4x | 0.8x |
| Interest coverage | — | — | — | — | — |
| Current ratio | 5.8x | 6.3x | 5.7x | 5.0x | 8.3x |
| Quick ratio | 5.1x | 5.5x | 4.8x | 4.1x | 7.3x |
Cash flow
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 4 of 9 | 7 of 9 | 6 of 9 |
| Rule of 40 | 20.9% | 62.2% | 41.3% |
| Altman Z'' | 7.06 | 7.37 | 6.80 |
| Accruals ratio | −0.1% | −0.4% | −8.5% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Pass | Fail |
| Current ratio rose | Fail | Fail | Pass |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Fail | Pass | Pass |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 4 of 9 | 7 of 9 | 6 of 9 |
Compare
Put Camtek side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Camtek | FY25 | 15.6% | 25.8% | 25.7% | 16.8% | 1.9x | 6 | |
| Cohu | FY25 | 12.7% | −15.4% | 2.4% | −9.1% | — | 5 | Compare |
| Veeco Instruments | FY25 | −7.4% | 5.4% | 8.0% | 4.5% | −3.0x | 6 | Compare |
| FormFactor | FY25 | 2.8% | 7.3% | 1.5% | 6.8% | −2.7x | 5 | Compare |
| Axcelis Technologies | FY25 | −17.6% | 14.2% | 12.8% | — | — | — | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 79 | 94 | 123 | 134 | 156 | 270 | 321 | 315 | 429 | 496 |
| Revenue growth | 14.2% | 18.0% | 31.8% | 8.8% | 16.3% | 73.0% | 19.0% | −1.7% | 36.1% | 15.6% |
| Gross profit | 32 | 46 | 61 | 65 | 73 | 137 | 160 | 148 | 210 | 250 |
| Research and development | 13 | 14 | 15 | 16 | 20 | 24 | 29 | 32 | 38 | 48 |
| Operating income | 2 | −3 | 20 | 22 | 23 | 71 | 82 | 65 | 108 | 128 |
| Net income | 5 | 14 | 19 | 22 | 22 | 60 | 80 | 79 | 118 | 51 |
| Diluted EPS (US$) | 0.13 | 0.39 | 0.51 | 0.57 | 0.54 | 1.34 | 1.68 | 1.63 | 2.42 | 1.04 |
| Diluted shares (millions) | 35 | 36 | 37 | 38 | 40 | 45 | 48 | 49 | 49 | 50 |
| Cash flow | ||||||||||
| Cash from operations | −17 | 2 | 17 | 25 | 26 | 61 | 58 | 79 | 122 | 142 |
| Capital expenditure | 1 | 3 | 2 | 1 | 2 | 4 | 8 | 8 | 10 | 14 |
| Free cash flow | −19 | −2 | 15 | 23 | 23 | 57 | 50 | 71 | 112 | 127 |
| Dividends paid | 0 | 5 | 5 | 7 | 0 | 0 | 0 | 0 | 60 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 0 | 1 | 2 | 3 | 4 | 6 | 10 | 13 | 14 | 17 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 20 | 44 | 55 | 38 | 106 | 242 | 148 | 139 | 157 | 257 |
| Debt incl. finance leases | — | — | — | — | 0 | 195 | 196 | 197 | 203 | 525 |
| Total assets | 106 | 113 | 142 | 170 | 288 | 584 | 677 | 788 | 892 | 1,260 |
| Total liabilities | 32 | 29 | 40 | 34 | 61 | 290 | 293 | 312 | 343 | 643 |
| Shareholders' equity | 73 | 84 | 101 | 136 | 227 | 294 | 384 | 476 | 549 | 617 |
| Margins and ratios | ||||||||||
| Gross margin | 41.0% | 48.7% | 49.4% | 48.3% | 47.0% | 50.9% | 49.8% | 46.8% | 48.9% | 50.5% |
| Operating margin | 2.5% | −3.2% | 16.3% | 16.4% | 14.5% | 26.3% | 25.4% | 20.7% | 25.2% | 25.8% |
| Net margin | 6.0% | 14.9% | 15.2% | 16.4% | 14.0% | 22.4% | 24.9% | 24.9% | 27.6% | 10.2% |
| Free cash flow margin | −23.5% | −1.6% | 11.8% | 17.4% | 15.0% | 21.1% | 15.5% | 22.6% | 26.1% | 25.7% |
| Rule of 40 (growth + FCF margin) | −9.3% | 16.4% | 43.6% | 26.2% | 31.3% | 94.1% | 34.5% | 20.9% | 62.2% | 41.3% |
| Return on capital | — | — | — | — | — | 32.3% | 21.8% | 12.2% | 17.3% | 16.8% |
| Return on equity | 6.7% | 17.7% | 20.2% | 18.5% | 12.0% | 23.1% | 23.6% | 18.3% | 23.1% | 8.7% |
| Return on assets | 4.3% | 12.8% | 14.7% | 14.1% | 9.5% | 13.8% | 12.7% | 10.7% | 14.1% | 4.7% |
| Net debt to EBITDA | — | — | — | — | −4.3x | −0.6x | 0.6x | 0.8x | 0.4x | 1.9x |